SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
- Status
- COMPLETED
- Phase
- PHASE3
Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases
- Status
- COMPLETED
- Phase
- N/A
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
- Status
- TERMINATED
- Phase
- NA
Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I/II Study of Ganetespib in Combination With Doxorubicin
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and Etoposide
- Status
- WITHDRAWN
- Phase
- N/A
BMS-986012 in Relapsed/Refractory SCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC
- Status
- COMPLETED
- Phase
- PHASE2